GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » New Horizon Health Ltd (HKSE:06606) » Definitions » Other Current Receivables

New Horizon Health (HKSE:06606) Other Current Receivables : HK$0 Mil (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is New Horizon Health Other Current Receivables?

New Horizon Health's Other Current Receivables for the quarter that ended in Jun. 2023 was HK$0 Mil.

New Horizon Health's annual Other Current Receivables declined from Dec. 2020 (HK$57.74 Mil) to Dec. 2021 (HK$0.62 Mil) but then increased from Dec. 2021 (HK$0.62 Mil) to Dec. 2022 (HK$33.56 Mil).


New Horizon Health Other Current Receivables Historical Data

The historical data trend for New Horizon Health's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

New Horizon Health Other Current Receivables Chart

New Horizon Health Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22
Other Current Receivables
161.89 85.71 57.74 0.62 33.56

New Horizon Health Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Other Current Receivables Get a 7-Day Free Trial Premium Member Only 57.82 0.62 - 33.56 -

New Horizon Health Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


New Horizon Health Other Current Receivables Related Terms

Thank you for viewing the detailed overview of New Horizon Health's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


New Horizon Health (HKSE:06606) Business Description

Traded in Other Exchanges
Address
400 Jiang’er Road, 13th Floor, T1 Building, Binjiang District, Zhejiang, Hangzhou, CHN, 310052
New Horizon Health Ltd is engaged in early cancer screening and in-home testing in China. The company has an early detection and cancer screening-focused pipeline of five products and product candidates with an emphasis on colorectal cancer screening. The company focuses on cancer prevention and cure through screening and early detection. It generates maximum revenue from ColoClear and Pupu Tube products.

New Horizon Health (HKSE:06606) Headlines

No Headlines